Startseite

Flurbiprofen

Flurbiprofen

Spezifikationen

5104-49-4CAS-Nummer
225-827-6EG-Nummer
2-(3-fluoro-4-phenylphenyl)propanoic acidIUPAC-Name
C15H13FO2Chemische Formel
244.26 g/molMolekulargewicht
flurbiprofen; 5104-49-4; Ansaid; Froben; Antadys; 2-(3-fluoro-4-phenylphenyl)propanoic acid; 2-(2-fluorobiphenyl-4-yl)propanoic acid; Cebutid; Flubiprofen; Flurbiprofene; Flurbiprofeno; 3-Fluoro-4-phenylhydratropic acid; Zepolas; Flurbiprofenum; BTS-18322; U-27182; BTS 18322; (+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid; 2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid; DTXSID0037231; 5GRO578KLP; BTS 18,322; NSC-757037; CHEBI:5130; U-27,182; DTXCID8017231; NSC685701; Fluriproben; (1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-, (+-)-; Froben Sr; Strefen; Novo Flurprofen; Nu Flurbiprofen; Apo Flurbiprofen; Rinol-STroche; ratio Flurbiprofen; RefChem:55218; 2-Fluoro-alpha-methyl(1,1'-biphenyl)-4-acetic acid; Antiphlamine Pain Relieving; M01AE09; M02AA19; R02AX01; S01BC04; BTS18322; (2RS)-2-(2-Fluorobiphenyl-4-yl)propanoic acid; 225-827-6; Flurofen; Ocufen; Flurbiprofene [INN-French]; Flurbiprofenum [INN-Latin]; Flurbiprofeno [INN-Spanish]; MFCD00079303; 2-(2-FLUORO-[1,1'-BIPHENYL]-4-YL)PROPANOIC ACID; FP 70; Stayban; 51543-38-5; Adfeed; U 27182; 2-(2-Fluoro-4-biphenylyl)propionic acid; (+/-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid; 2-(2-Fluoro-1,1'-biphenyl-4-yl)propanoic acid; CHEMBL563; 2-Fluoro-alpha-methyl-4-biphenylacetic acid; MLS000040873; 2-(3-fluoro-4-phenyl-phenyl)propanoic acid; Flugalin; Anmetarin; SMR000042823; Yakuban; 2-(2-Fluoro[1,1'-biphenyl]-4-yl)propanoic acid; Ocuflur; 2-(2-Fluorobiphenyl-4-yl)propionic Acid; Flurbiprofen (Ansaid); Ansaid (TN); CCRIS 3708; (S)-2-(2-fluorobiphenyl-4-yl)propanoic acid; SR-01000003043; FLP; (R)-Flurbiprofen;MPC7869; EINECS 225-827-6; (+-)-2-(2-Fluoro-4-biphenylyl)propionic acid; UNII-5GRO578KLP; U 27,182; Flurbiprofen; (2RS)-2-(2-Fluorobiphenyl-4-yl)propanoic acid; Flurbiprofen O; MKS-11; rac-Flurbiprofen; s1679; Froben;; Flurbiprofen CRS; 2-(2-FLUORO-4-BIPHENYLYL)PROPANOIC ACID; NCGC00016654-01; (+-)Flurbiprofen; CAS-5104-49-4; EINECS 257-262-6; Ocufen (Salt/Mix); [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-?-methyl-; (1)-2-Fluoro-alpha-methyl(1,1'-biphenyl)-4-acetic acid; Flurbiprofen (NSAID); Flurbiprofen [USAN:USP:INN:BAN:JAN]; Spectrum_001096; Flurbiprofen (Standard); Opera_ID_777; Prestwick0_000917; Prestwick1_000917; Prestwick2_000917; Prestwick3_000917; Spectrum2_001025; Spectrum3_000435; Spectrum4_000558; Spectrum5_000720; FLURBIPROFEN [MI]; F0371; (.+/-.)-Flurbiprofen; Flurbiprofendl-Flurbiprofen; FLURBIPROFEN [INN]; FLURBIPROFEN [JAN]; Epitope ID:613431; 4-Biphenylacetic acid, 2-fluoro-alpha-methyl-; FLURBIPROFEN [USAN]; SCHEMBL2248; FLURBIPROFEN [VANDF]; 4-Biphenylacetic acid, 2-fluoro-.alpha.-methyl-; BSPBio_000794; BSPBio_002050; FLURBIPROFEN [MART.]; KBioGR_001255; KBioSS_001576; MLS000028441; MLS000758198; MLS001201729; MLS001401361; MLS006011431; MLS006011931; DivK1c_000804; FLURBIPROFEN [USP-RS]; FLURBIPROFEN [WHO-DD]; SPECTRUM1500308; 2-(2-fluoro-[1,1'-biphenyl-4-yl])propanoic acid; SPBio_001209; SPBio_002983; BPBio1_000874; GTPL4194; orb1224876; orb1310752; SCHEMBL10029029; Flurbiprofen (JP18/USP/INN); HMS502I06; KBio1_000804; KBio2_001576; KBio2_004144; KBio2_006712; KBio3_001270; SYTBZMRGLBWNTM-UHFFFAOYSA-; [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-.alpha.-methyl-; MSK7164; NINDS_000804; FLURBIPROFEN [ORANGE BOOK]; HMS1570H16; HMS1920O20; HMS2051A05; HMS2090I06; HMS2091F21; HMS2097H16; HMS2232I08; HMS3259I12; HMS3268E10; HMS3370N14; HMS3371I05; HMS3393A05; HMS3414N17; HMS3649K11; HMS3655G19; HMS3678N15; HMS3714H16; HMS5079N10; Pharmakon1600-01500308; FLURBIPROFEN [EP MONOGRAPH]; 2-FLUORO-[1,1'-BIPHENYL]-4-(ALPHA-METHYL)ACETIC ACID; FLURBIPROFEN [USP MONOGRAPH]; Tox21_110547; Tox21_302353; BBL010980; BDBM50074922; CCG-40243; EBC-26294; HB3049; HY-10582R; MSK7164-100M; NSC755404; NSC757037; SBB067242; STK802101; Flurbiprofen, cyclooxygenase inhibitor; AKOS004119934; AKOS016340701; MSK7164-1000M; AC-8106; CCG-100759; DB00712; FF23507; KS-5035; NC00009; NC00563; NSC 757037; NSC-685701; NSC-755404; 2(2-Fluoro-4-biphenylyl)propionic acid; Flurbiprofen for peak identification CRS; IDI1_000804; NCGC00018157-03; NCGC00018157-04; NCGC00018157-05; NCGC00018157-08; NCGC00018157-11; NCGC00018157-13; NCGC00025287-03; NCGC00025287-04; NCGC00255457-01; HY-10582; NCI60_030812; SY057091; 2 -(2-fluoro-4-biphenylyl)propionic acid; 2-(2-fluoro-4-biphenylyl)-propionic acid; 2-(2-fluoro-biphenyl-4-yl)propionic acid; SBI-0051387.P003; DB-051888; 2-(2-fluoro-biphenyl-4-yl)-propionic acid; AB00051999; F4481; Flurbiprofen Solution in Methanol, 100ug/mL; NS00003058; ST50825909; alpha-methyl-2-fluoro-4-biphenylylacetic acid; Flurbiprofen Solution in Methanol, 1000ug/mL; (RS)-2-(2-fluorobiphenyl-4-yl)propionic acid; 2-Fluoro-.alpha.-methyl-4-biphenylacetic acid; BIM-0051387.0001; C07013; D00330; AB00051999-17; AB00051999_18; EN300-7479231; 2-fluoro--methyl-(1,1'-biphenyl)-4-acetic acid; AO-295/42284050; F463477; Q419890; (.+/-.)-2-(2-Fluoro-4-biphenylyl)propionic acid; (r/s)-2-fluoro-alpha-methyl-4-biphenylacetic acid; SR-01000003043-2; SR-01000003043-5; SR-01000003043-6; 2-(2-fluoro-[1,1''-biphenyl-4-yl])propanoic acid; 2-(2-Fluoro[1,1'-biphenyl]-4-yl)propanoic acid #; BRD-A86044036-001-05-9; BRD-A86044036-001-26-5; BRD-A86044036-001-27-3; SR-01000003043-14; (+/-)-2-(2-FLUORO-4-BIPHENYLYL)PROPIONIC ACID; (.+/-.)-2-Fluoro-.alpha.-methyl-4-biphenylacetic acid; 2-Fluoro-.alpha.-methyl(1,1'-biphenyl)-4-acetic acid; 2-fluoro-alpha-methyl-(1,1''-biphenyl)-4-acetic acid; 2-Fluoro-alpha-methyl-[1,1'-biphenyl]-4-a cetic acid; 2-Fluoro-I<<-methyl-[1,1'-biphenyl]-4-a cetic acid; Z2216885233; (+/-)-2-FLUORO-.ALPHA.-METHYL-4-BIPHENYLACETIC ACID; [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-a-methyl-, (+/-)-; Flurbiprofen, European Pharmacopoeia (EP) Reference Standard; (1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-, (+/-)-; [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-a-methyl-, (A+/-)-; Flurbiprofen, United States Pharmacopeia (USP) Reference Standard; [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-.alpha.-methyl-, (.+/-.)-; 2-[2-Fluoro-[1,1 inverted exclamation mark -biphenyl]-4-yl]propanoic Acid; (1,1'-BIPHENYL)-4-ACETIC ACID, 2-FLUORO-.ALPHA.-METHYL-, (+/-)-; Flurbiprofen, 2-(2-Fluorobiphenyl-4-yl)propionic acid, 3-Fluoro-4-phenylhydratropic acid; Flurbiprofen, Pharmaceutical Secondary Standard; Certified Reference Material; 2-Fluoro-4-Iodo-1-isothiocyanatobenzene; 2-Fluoro-4-iodo-1-isothiocyanatobenzene; 2-Fluoro-4-iodophenyl isothiocyanate;; InChI=1/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)Synonyme